CORC

在结果中检索

CORC

浏览/检索结果: 共23条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020) 期刊论文
MOLECULAR CANCER, 2021, 卷号: 20, 期号: 1, 页码: 1
作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang
收藏  |  浏览/下载：58/0  |  提交时间：2021/11/04
Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文
Molecular Cancer, 2021, 卷号: 20, 期号: 1
作者:  Zhang,Tao;  Qu,Rong;  Chan,Shingpan;  Lai,Mengzhen;  Tong,Linjiang
收藏  |  浏览/下载：41/0  |  提交时间：2021/11/04
PGE2-JNK signaling axis non-canonically promotes Gli activation by protecting Gli2 from ubiquitin-proteasomal degradation 期刊论文
CELL DEATH & DISEASE, 2021, 卷号: 12, 期号: 7, 页码: 10
作者:  Yang, Jun;  Wang, Juan;  Liu, Yuan;  Zhang, Yu;  Huang, Wenjing
收藏  |  浏览/下载：43/0  |  提交时间：2021/08/17
SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014) 期刊论文
CANCER LETTERS, 2020, 卷号: 486, 页码: 71-72
作者:  Wang, Lu;  Ai, Jing;  Shen, Yanyan;  Zhang, Haotian;  Peng, Xia
收藏  |  浏览/下载：10/0  |  提交时间：2020/12/24
Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed 期刊论文
SCIENCE ADVANCES, 2020, 卷号: 6, 期号: 25, 页码: 13
作者:  Fang, Lei;  Zhao, Zitong;  Wang, Jue;  Zhang, Pengcheng;  Ding, Yaping
收藏  |  浏览/下载：23/0  |  提交时间：2020/12/24
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文
MOLECULAR CANCER, 2020, 卷号: 19, 期号: 1, 页码: 15
作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang
收藏  |  浏览/下载：41/0  |  提交时间：2020/07/01
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models. 期刊论文
CANCER IMMUNOLOGY RESEARCH, 2020, 卷号: 8, 期号: 3, 页码: 70-70
作者:  Dai, Yang;  Ji, Yichun;  Shen, Yanyan;  Su, Yi;  Liu, Bo
收藏  |  浏览/下载：26/0  |  提交时间：2020/07/01
discoveryandbiologicalevaluationofn372methoxy44methylpiperazin1ylphenylamino4methyl2oxo2hpyrimido45d13oxazin14hylphenylacrylamideaspotentbrutonstyrosinekinaseinhibitors 期刊论文
actapharmacologicasinica, 2020, 卷号: 41, 期号: 3, 页码: 415
作者:  Lai Mengzhen;  Song Peiran;  Dou Dou;  Diao Yanyan;  Tong Linjiang
收藏  |  浏览/下载：29/0  |  提交时间：2020/07/01
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models 期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 期号: 1, 页码: 16
作者:  Peng, Xia;  Hou, Pengcong;  Chen, Yi;  Dai, Yang;  Ji, Yinchun
收藏  |  浏览/下载：7/0  |  提交时间：2020/07/01
Discovery and Biological evaluation of pyrimido[4,5-d] pyrimidine-2,4(1H, 3H)-dione derivatives as potent Bruton's tyrosine kinase inhibitors 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 卷号: 27, 期号: 15, 页码: 3390-3395
作者:  Diao, Yanyan;  Fang, Xiaoyu;  Song, Peiran;  Lai, Mengzhen;  Tong, Linjiang
收藏  |  浏览/下载：23/0  |  提交时间：2020/07/01

©版权所有 ©2017 CSpace - Powered by CSpace